Cargando…

Reactive oxygen species-triggered off-on fluorescence donor for imaging hydrogen sulfide delivery in living cells

Hydrogen sulfide (H(2)S), an important gasotransmitter, can mediate a variety of pathophysiological processes, and H(2)S-based donors have been intensively explored for the therapy of cardiovascular injury, nerve damage and intestinal disorders. However, most of the H(2)S donors are not capable of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yiming, Li, Xiaoyi, Fang, Yu, Shi, Wen, Li, Xiaohua, Chen, Wei, Xian, Ming, Ma, Huimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836935/
https://www.ncbi.nlm.nih.gov/pubmed/31803407
http://dx.doi.org/10.1039/c9sc02323b
Descripción
Sumario:Hydrogen sulfide (H(2)S), an important gasotransmitter, can mediate a variety of pathophysiological processes, and H(2)S-based donors have been intensively explored for the therapy of cardiovascular injury, nerve damage and intestinal disorders. However, most of the H(2)S donors are not capable of simultaneously real-time tracking intracellular H(2)S delivery, which limits their biological application for elucidating the specific function of H(2)S. Herein we develop the first reactive oxygen species (ROS)-triggered off-on fluorescence H(2)S donor (NAB) by incorporating ROS-responsive arylboronate into a fluorophore through thiocarbamate. The donor NAB can release carbonyl sulfide (COS) and the fluorophore with a fluorescence off-on response via a ROS-triggered self-immolative reaction, and then COS is quickly converted to H(2)S by the ubiquitous carbonic anhydrase. This dual function makes NAB suitable for not only in situ and real-time monitoring of the intracellular H(2)S release but also rescuing RAW264.7 cells from the hazardous oxidative environment under the stimulation of phorbol-12-myristate-13-acetate, revealing the possible potential of NAB as a therapeutic prodrug with the fluorescence imaging capacity.